Vol. 18/No. 04 | OncologyLive

CARs Ready to Roll

March 05, 2017

Although the concept of using genetically engineered T cells to fight cancer has been under study for more than 50 years, the most dramatic strides in designing new therapies have come in the past several years.

PARP Inhibitors Are Changing Paradigm in Recurrent Ovarian Cancer

March 02, 2017

A panel of gynecologic oncology specialists discusses novel agents for the second, third, fourth, and even fifth lines of therapy and the growing importance of molecular signature, histology, and time to recurrence in treatment decisions.

A Master Mentor Who Nurtured a Field

February 27, 2017

Robert J. Mayer, MD, who helped the field of oncology develop while conducting groundbreaking research, was honored in the Gastrointestinal Cancer category with a 2015 Giants of Cancer Care® award, a program that OncLive developed to recognize leaders in the field.

Clinical Trial Reform Is Urgently Needed

February 23, 2017

The current status of clinical cancer research in the United States falls far short of what is necessary to effectively and efficiently change this amazing opportunity to improve both the quantity and quality of the lives of patients with cancer into an objective reality.